AWAITS: A Web-based E-health Application for Active Illicit Opioid Users
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 8/18/2018 |
| Start Date: | November 8, 2017 |
| End Date: | November 2018 |
A Web-based E-health Application for Active Illicit Opioid Users Providing Information About Overdose and Infection Risk Factors and Encouraging HCV/HIV Testing and Medication Assisted Treatment Seeking
The purpose of this research study is to:
1. assess how participants like the AWAITS e-health application as measured by their
feedback on the intervention
2. test the impact of AWAITS on knowledge about opioid overdose and risk-reduction
strategies.
3. assess the proportion of participants who accept a list of local treatment providers
4. test the impact of AWAITS on interest in being tested for HCV/HIV.
1. assess how participants like the AWAITS e-health application as measured by their
feedback on the intervention
2. test the impact of AWAITS on knowledge about opioid overdose and risk-reduction
strategies.
3. assess the proportion of participants who accept a list of local treatment providers
4. test the impact of AWAITS on interest in being tested for HCV/HIV.
The pre-post study of AWAITS will: 1) assess the acceptability of AWAITS as measured by
participant feedback about the intervention; 2) test the impact of AWAITS on knowledge about
opioid overdose, as measured by the OOTAS; 3) assess the proportion of participants who
accept a list of local MAT treatment providers; and 4) test the impact of AWAITS on interest
in being tested for HCV/HIV.
The acceptability of AWAITS will be assessed with a feedback form which includes questions
about how helpful the intervention was (scale of 1-4), what the patient liked most and least
about the intervention, and any suggestions for improving it. The average (and standard
deviation) for the rated helpfulness of the intervention will be derived and the qualitative
data about what they liked most and least about the intervention and suggestions for
improvement will be tabulated. Pre-/post-changes in the percent of correct knowledge
assessment items (i.e., about overdose and MAT) and interest in HCV/HIV testing will be
analyzed using a Wilcoxon signed-rank test. The proportion of participants accepting a list
of local MAT treatment providers will be calculated.
participant feedback about the intervention; 2) test the impact of AWAITS on knowledge about
opioid overdose, as measured by the OOTAS; 3) assess the proportion of participants who
accept a list of local MAT treatment providers; and 4) test the impact of AWAITS on interest
in being tested for HCV/HIV.
The acceptability of AWAITS will be assessed with a feedback form which includes questions
about how helpful the intervention was (scale of 1-4), what the patient liked most and least
about the intervention, and any suggestions for improving it. The average (and standard
deviation) for the rated helpfulness of the intervention will be derived and the qualitative
data about what they liked most and least about the intervention and suggestions for
improvement will be tabulated. Pre-/post-changes in the percent of correct knowledge
assessment items (i.e., about overdose and MAT) and interest in HCV/HIV testing will be
analyzed using a Wilcoxon signed-rank test. The proportion of participants accepting a list
of local MAT treatment providers will be calculated.
Inclusion Criteria:
1. At least 18 years of age
2. Not enrolled in MAT per self-report
3. Self-reports illicit opioid use
Exclusion Criteria:
3. Does not acknowledge reviewing "Information Sheet for Research" within REDCap
We found this trial at
1
site
Click here to add this to my saved trials
